Cognitive problems are common in children with neurofibromatosis type 1 and they can often complicate treatment. The current literature review examines cognitive functioning in neurofibromatosis type 1, with a specific focus on executive functioning. This includes exploration of how deficits in executive functioning are expressed in children with neurofibromatosis type 1 and how these deficits contrast with ADHD. The value of investigating subcomponents of executive functioning is discussed, as are implications for effective treatment and future research.
American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
2.
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author.
3.
BiedermanJ.MickE.FaraoneS. V.BraatenE.DoyleA.SpencerT.. . . JohnsonM. A. (2002). Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. American Journal of Psychiatry, 159, 36-42.
4.
BillingsleyR. L.JacksonE. F.SlopisJ. M.SwankP. R.MahankaliS.MooreB. D. (2003). Functional magnetic resonance imaging of phonological processing in neurofibromatosis 1. Journal of Child Neurology, 18, 731-740.
5.
BillingsleyR. L.JacksonE. F.SlopisJ. M.SwankP. R.MahankaliS.MooreB. D. (2004). Functional MRI of visual–spatial processing in neurofibromatosis, Type I. Neuropsychologia, 42, 395-404.
6.
BrewerV. R.MooreB. D.HiscockM. (1997). Learning disability subtypes in children with neurofibromatosis. Journal of Learning Disabilities, 30, 521-533.
7.
BrownJ. A.EmnettR. J.WhiteC. R.YuedeC. M.ConyersS. B.O’MalleyK. L.. . . GutmannD. H. (2010). Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice. Human Molecular Genetics, 19, 4515-4528.
8.
ChabernaudC.SirinelliD.BarbierC.CottierJ. P.SembelyC.GiraudeauB.. . . CastelnauP. (2009). Thalamo-striatal T2-weighted hyperintensities (unidentified bright objects) correlate with cognitive impairments in neurofibromatosis Type 1 during childhood. Developmental Neuropsychology, 34, 736-748.
9.
ChapmanC. A.WaberD. P.BassettN.UrionD. K.KorfB. R. (1996). Neurobehavioral profiles of children with neurofibromatosis 1 referred for learning disabilities are sex-specific. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 67, 127-132.
10.
Clements-StephensA. M.RimrodtS. L.GaurP.CuttingL. E.(2008). Visuospatial processing in children with neurofibromatosis Type 1. Neuropsychologia, 46, 690-697.
11.
CostaR. M.FederovN. B.KoganJ. H.MurphyG. G.SternJ.OhnoM.. . . SilvaA. J. (2002). Mechanism for the learning deficits in a mouse model of neurofibromatosis Type 1. Nature, 415, 526-530.
12.
CoudeF. X.MignotC.LyonnetS.MunnichA. (2007). Early grade repetition and inattention associated with neurofibromatosis Type 1. Journal of Attention Disorders, 11, 101-105.
13.
DencklaM. B. (1996). Neurofibromatosis Type 1: A model for the pathogenesis of reading disability. Mental Retardation and Developmental Disabilities Research Reviews, 2, 48-53.
14.
DescheemaekerM. J.GhesquiereP.SymonsH.FrynsJ. P.LegiusE. (2005). Behavioural, academic and neuropsychological profile of normally gifted neurofibromatosis Type 1 children. Journal of Intellectual Disability Research, 49, 33-46.
15.
DiamondA. (2005). Attention-deficit disorder (attention-deficit/hyperactivity disorder without hyperactivity): A neurobiologically and behaviorally distinct disorder from attention-deficit/hyperactivity disorder (with hyperactivity). Development and Psychopathology, 17, 807-825.
DosenbachN. U. F.FairD. A.MiezinF. M.CohenA. L.WengerK. K.DosenbachR. A. T.. . . PetersenS. E. (2007). Distinct brain networks for adaptive and stable task control in humans. Proceedings of the National Academy of Sciences of the United States of America, 104, 11073-11078.
18.
EliasonM. J. (1986). Neurofibromatosis: Implications for learning and behavior. Journal of Developmental & Behavioral Pediatrics, 7, 175-179.
19.
FairD. A.DosenbachN. U. F.ChurchJ. A.CohenA. L.BrahmbhattS.MiezinF. M.. . . SchlaggarB. L. (2007). Development of distinct control networks through segregation and integration. Proceedings of the National Academy of Sciences of the United States of America, 104, 13507-13512.
20.
FairD. A.PosnerJ.NagelB. J.BathulaD.DiasT. G. C.MillsK. L.. . . NiggJ. T. (2010). Atypical default network connectivity in youth with attention-deficit/hyperactivity disorder. Biological Psychiatry, 68, 1084-1091.
21.
FeldmannR.SchuiererG.WesselA.NevelingN.WeglageJ.(2010). Development of MRI T2 hyperintensities and cognitive functioning in patients with neurofibromatosis Type 1. Acta Peadiatrica, 99, 1657-1660.
22.
FernerR. E.GutmannD. H. (2002). International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis 1. Cancer Research, 62, 1573-1577.
23.
FernerR. E.HughesR. A. C.WeinmanJ. (1996). Intellectual impairment in neurofibromatosis 1. Journal of the Neurological Sciences, 138, 125-133.
24.
Ferraz-FilhoJ. R. L.da RochaA. J.MunizM. P.SouzaA. S.Goloni-BertolloE. M.Pavarino-BertelliE. C. (2011). Diffusion tensor MR imaging in neurofibromatosis Type 1: Expanding the knowledge of microstructural brain abnormalities. Pediatric Radiology. Advance online publication. doi:10.1007/s00247-011-2274-1.
25.
GohW. H. S.KhongP. L.LeungC. S. Y.WongV. C. N. (2004). T-2-weighted hyperintensities (unidentified bright objects) in children with neurofibromatosis 1: Their impact on cognitive function. Journal of Child Neurology, 19, 853-858.
26.
GutmannD. H.AylsworthA.CareyJ. C.KorfB.MarksJ.PyeritzR. E.. . . ViskochilD. (1997). The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1and neurofibromatosis 2. Journal of the American Medical Association, 278, 51-57.
27.
HaleJ. B.ReddyL. A.DeckerS. L.ThompsonR.HenzelJ.TeodoriA.. . . DencklaM. B. (2009). Development and validation of an attention-deficit/hyperactivity disorder (ADHD) executive function and behavior rating screening battery. Journal of Clinical and Experimental Neuropsychology, 31, 897-912.
28.
HinshawS. P. (2006). Is the inattentive type of ADHD a separate disorder?Clinical Psychology: Science and Practice, 8, 498-501.
29.
HofmanK. J.HarrisE. L.BryanR. N.DencklaM. B. (1994). Neurofibromatosis Type 1: The cognitive phenotype. Journal of Pediatrics, 124, S1-S8.
30.
HuijbregtsS.SwaabH.de SonnevilleL. (2010). Cognitive and motor control in neurofibromatosis Type I: Influence of maturation and hyperactivity-inattention. Developmental Neuropsychology, 35, 737-751.
31.
HusonS. M.CompstonD. A.ClarkP.HarperP. S. (1989). A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. Journal of Medical Genetics, 26, 704-711.
32.
HymanS. L.ArthurE.NorthK. N. (2006). Learning disabilities in children with neurofibromatosis Type 1: Subtypes, cognitive profile, and attention-deficit-hyperactivity disorder. Developmental Medicine & Child Neurology, 48, 973-977.
33.
HymanS. L.GillD. S.ShoresE. A.SteingburgA.NorthK. N. (2007). T2 hyperintensities in children with neurofibromatosis Type 1 and their relationship to cognitive functioning. Journal of Neurology, Neurosurgery & Psychiatry, 78, 1088-1091.
34.
HymanS. L.ShoresA.NorthK. N. (2005). The nature and frequency of cognitive deficits in children with neurofibromatosis Type 1. Neurology, 65, 1037-1044.
35.
JohnsonH.WiggsL.StoresG.HusonS. M. (2005). Psychological disturbance and sleep disorders in children with neurofibromatosis Type 1. Developmental Medicine & Child Neurology, 47, 237-242.
36.
JohnsonN. S.SaalH. M.LovellA. M.SchorryE. K. (1999). Social and emotional problems in children with neurofibromatosis Type 1: Evidence and proposed interventions. Journal of pediatrics, 134, 767-772.
37.
JohnstonM. V. (2004). Clinical disorders of brain plasticity. Brain & Development, 26, 73-80.
38.
KaylA. E.MooreB. D.SlopisJ. M.JacksonE. F.LeedsN. E. (2000). Quantitative morphology of the corpus callosum in children with neurofibromatosis and attention-deficit hyperactivity disorder. Journal of Child Neurology, 15, 90-96.
39.
KonradA.DielentheisT. F.El MasriD.BayerlM.FehrC.GesierichT.. . . WintererG. (2010). Disturbed structural connectivity is related to inattention and impulsivity in adult attention deficit hyperactivity disorder. European Journal of Neuroscience, 31, 912-919.
40.
KothC. W.CuttingL. E.DencklaM. B. (2000). The association of neurofibromatosis Type 1 and attention deficit hyperactivity disorder. Child Neuropsychology, 6, 185-194.
41.
KrabL. C.de Goede-BolderA.AarsenF. K.PluijmS. M. F.BoumanM. J.van der GeestJ. N.. . . ElgersmaY. (2008). Effect of simvastatin on cognitive functioning in children with neurofibromatosis Type 1: A randomized controlled trial. Journal of the American Medical Association, 300, 287-294.
42.
LiW.CuiY.KushnerS. A.BrownR. A. M.JentschJ. D.FranklandP. W. (2005). The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis Type 1. Current Biology, 15, 1961-1967.
43.
MautnerV. F.KluweL.ThakkerS. D.LearkR. A. (2002). Treatment of ADHD in neurofibromatosis Type 1. Developmental Medicine and Child Neurology, 44, 164-170.
44.
MazzoccoM. M. M.TurnerJ. E.DencklaM. B.HofmanK. J.ScanlonD. C.VellutinoF. R. (1995). Language and reading deficits associated with neurofibromatosis Type 1: Evidence for a not-so-nonverbal learning disability. Developmental Neuropsychology, 11, 503-522.
45.
MooreB. D.AterJ. L.NeedleM. N.SlopisJ.CopelandD. R. (1994). Neuropsychological profile of children with neurofibromatosis, brain tumor, or both. Journal of Child Neurology, 9, 368-377.
46.
MooreB. D.SlopisJ. M. (1995). Neuropsychological significance of high signal intensities on brain MRI of children with neurofibromatosis-Type-1. Pediatric Research, 37, A17-A17.
47.
MooreB. D.SlopisJ. M.JacksonE. F.De WinterA. E.LeedsN. E. (2000). Brain volume in children with neurofibromatosis Type 1—Relation to neuropsychological status. Neurology, 54, 914-920.
48.
NollR. B.Reiter-PurtillJ.MooreB. D.SchorryE. K.LovellA. M.VannattaK.GerhardtC. A. (2007). Social, emotional, and behavioral functioning of children with NF1. American Journal of Medical Genetics Part A, 143, 2261-2273.
49.
NorthK.JoyP.YuilleD.CocksN.HutchinsP. (1995). Cognitive function and academic performance in children with neurofibromatosis Type 1. Developmental Medicine & Child Neurology, 37, 427-436.
50.
NorthK.JoyP.YuilleD.CocksN.MobbsE.HutchinsP.. . . de SilvaM. (1994). Specific learning disability in children with neurofibromatosis Type 1: Significance of MRI abnormalities. Neurology, 44, 878-883.
51.
OzonoffS. (1999). Cognitive impairment in neurofibromatosis Type 1. American Journal of Medical Genetics, 89, 45-52.
52.
PayneJ. M.MoharirM. D.WebsterR.NorthK. N. (2010). Brain structure and function in neurofibromatosis Type 1: Current concepts and future directions. Journal of Neurology, Neurosurgery & Psychiatry, 81, 304-309.
53.
PrestonA. S.FennellE. B.BussingR. (2005). Utility of a CPT in diagnosing ADHD among a representative sample of high-risk children: A cautionary study. Child Neuropsychology, 11, 459-469.
54.
PrideN.PayneJ. M.WebsterR.ShoresE. A.RaeC.NorthK. N. (2010). Corpus callosum morphology and its relationship to cognitive function in neurofibromatosis Type 1. Journal of Child Neurology, 25, 834-841.
55.
RowbothamI.Pit-ten CateI. M.Sonuga-BarkeE. J. S.HuijbregtsS. C. J. (2009). Cognitive control in adolescents with neurofibromatosis Type 1. Neuropsychology, 23, 50-60.
56.
RoyA.RoulinJ.-L.CharbonnierV.AllainP.FasottiL.BarbarotS.. . . Le GallD. (2010). Executive dysfunction in children with neurofibromatosis Type 1: A study of action planning. Journal of the International Neuropsychological Society, 16, 1056-1063.
Sonuga-BarkeE.BitsakouP.ThompsonM. (2010). Beyond the dual pathway model: Evidence for the dissociation of timing, inhibitory, and delay-related impairments in attention-deficit/hyperactivity disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 49, 345-355.
59.
StefanatosG. A.BaronI. S. (2007). Attention-deficit/hyperactivity disorder: A neuropsychological perspective towardsDSM-V. Neuropsychology Review, 17, 5-38.
60.
van EngelenS. J.KrabL. C.MollH. A.de Goede-BolderA.PluijmS. M.Catsman-BerrevoetsC. E.LequinM. H. (2008). Quantitative differentiation between healthy and disordered brain matter in patients with neurofibromatosis Type I using diffusion tensor imaging. American Journal of Neuroradiology, 29, 816-822.
61.
WignallE. L.GriffithsP. D.PapadakisN. G.WilkinsonI. D.WallisL. I.BandmannO.. . . HoggardN. (2010). Corpus callosum morphology and microstructure assessed using structural MR imaging and diffusion tensor imaging: Initial findings in adults with neurofibromatosis Type 1. American Journal of Neuroradiology, 31, 856-861.
